Pharmaceuticals
Healthcare
InvAscent hits first close for new healthcare fund; strikes back-to-back PE deal
Homegrown healthcare-focussed private equity fund InvAscent has hit the first close for its latest vehicle, even as it ......
Healthcare
Eris Lifesciences acquires two businesses from Biocon arm
Private equity firm ChrysCapital and Kuwait Investment Authority-backed listed pharmaceutical company Eris Lifesciences......
Healthcare
QHP Capital strikes an India-linked bolt-on deal; local PE firm gets an exit
QHP Capital, which started as a corporate venture arm of Quintiles (now IQVIA) and later spun out as NovaQuest that ......
Healthcare
Torrent Pharma in talks with multiple PE players for loan to partially fund Cipla bid
India's Torrent Pharmaceuticals is in preliminary talks with Apollo Global Management to secure a loan of up to $1 ......
Healthcare
Concord Biotech gains 27% on stock market debut as valuation tops $1 bn
Concord Biotech, a pharmaceutical ingredients maker, made a strong stock market debut on Friday with its shares listing at a ......
Healthcare
Biocon may list biosimilars business by 2025 first half: CEO
Indian biopharmaceutical company Biocon Ltd is planning to list its biosimilars business, a significant contributor to ......
Healthcare
Advent may rope in new investor for Bharat Serums with neat valuation markup
Mumbai-based biopharmaceutical company Bharat Serums, controlled by private equity major Advent International, is ......
Healthcare
ChrysCap-backed Corona Remedies buys Sanofi's muscle relaxant brand
Ahmedabad-based Corona Remedies, which counts private equity firm ChrysCapital as an investor, has bought drugmaker ......
Finance
PAG-backed Sekhmet appoints former Jubilant Ingrevia head as CEO
Sekhmet Pharmaventures, a pharmaceutical investment platform backed by Asia-Pacific focused private equity investor PAG......
Healthcare
Mankind Pharma valuation nears $7 bn as shares jump on listing
Shares of Manforce condom maker Mankind Pharma Ltd surged as much as 32% in its first session on Tuesday, valuing ......